To evaluate the impact of ARL4C inhibition on sepsis in vitro, lentivirus-shARL4C was introduced into RAW264.7 cells, and flow cytometry was employed to assess apoptotic levels and ROS production among the various groups. Here, ARL4C is linked to Sepsis.